ÔçÒÒŮѸÀ×

    1. <form id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></form>
      <address id=SSjMaZxIp><nobr id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></nobr></address>

      USA Passive

      iShares U.S. Healthcare ETF

      The iShares U.S. Healthcare ETF (the ¡°Fund¡±) seeks to track the investment results of an index composed of U.S. equities in the healthcare sector.

      $58.21

      Compare similar ETFs

      Fund Size
      Dividend
      Fees
      Current
      U.S. Healthcare ETF IYH
      Fund Size
      $3B
      Dividend
      1.3%
      Fees
      0.39%
      Core S&P 500 ETF IVV
      Fund Size
      $626B
      Dividend
      1.2%
      Fees
      0.03%
      Core U.S. Aggregate Bond ETF AGG
      Fund Size
      $128B
      Dividend
      3.8%
      Fees
      0.03%
      S&P 500 Equal Weight ETF RSP
      Fund Size
      $73B
      Dividend
      1.5%
      Fees
      -
      Schwab U.S. Dividend Equity ETF SCHD
      Fund Size
      $68.2B
      Dividend
      3.7%
      Fees
      0.06%
      View 400 similar ETFs →

      Average metrics of all companies in portfolio

      Compare to
      Market
      Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $254B
      Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. 1.42 %
      Beta Indicates the relationship between the price performance of a share and the market. 0.6491
      P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 38.06
      Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything -64.97
      Profitable Companies 94
      PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 263.85
      Price to Sales Ratio Market cap divided by the revenue in the most recent year. 6.76
      Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 15.02
      Compare to
      Market
      Enterprise Value to EBIT Enterprise Value divided by EBIT 32.55
      Enterprise Value to Revenue Enterprise value divided by revenue 7.59
      Total Debt to Enterprise Value Total debt divided by enterprise value 0.11
      Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. NaN
      Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. 14.96%
      Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. -
      Return on Equity Equity divided by market cap. 52.73%
      Return on Assets Indicates a company's profitability in relation to its total assets. 13.43%
      Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. 16.25%

      Industries

      Healthcare 70.1%
      Finance 4.7%
      Industrials 3.7%
      Other 3.7%
      Technology 2.8%
      N/A 15.0%

      Market cap

      Micro Cap 0%
      Small Cap 0%
      Mid Cap 3%
      Large Cap 56%
      Mega Cap 41%

      107 Investments

      P/E-Ratio
      Total Investment
      Weight
      ELI LILLY AND COMPANY logo

      LLY - Manufacturing

      ELI LILLY AND COMPANY

      P/E-Ratio
      47.7
      Total Investment
      $407M
      Weight
      13.7%
      UNITEDHEALTH GROUP INCORPORATED logo

      UNH - Finance and Insurance

      UNITEDHEALTH GROUP INCORPORATED

      P/E-Ratio
      13.2
      Total Investment
      $214M
      Weight
      7.2%
      JOHNSON & JOHNSON logo

      JNJ - Manufacturing

      JOHNSON & JOHNSON

      P/E-Ratio
      18.9
      Total Investment
      $213M
      Weight
      7.2%
      ABBVIE INC. logo

      ABBV - Manufacturing

      ABBVIE INC.

      P/E-Ratio
      98.9
      Total Investment
      $196M
      Weight
      6.6%
      ABBOTT LABORATORIES logo

      ABBOTT LABORATORIES

      P/E-Ratio
      n/a
      Total Investment
      $128M
      Weight
      4.3%
      MERCK & CO., INC. logo

      MERCK & CO., INC.

      P/E-Ratio
      n/a
      Total Investment
      $122M
      Weight
      4.1%
      INTUITIVE SURGICAL, INC. logo

      ISRG - Manufacturing

      INTUITIVE SURGICAL, INC.

      P/E-Ratio
      65.1
      Total Investment
      $103M
      Weight
      3.5%
      THERMO FISHER SCIENTIFIC INCORPORATED logo

      TMO - Professional, Scientific, and Technical Services

      THERMO FISHER SCIENTIFIC INCORPORATED

      P/E-Ratio
      28.3
      Total Investment
      $92.7M
      Weight
      3.1%
      AMGEN INC. logo

      AMGN - Manufacturing

      AMGEN INC.

      P/E-Ratio
      23.4
      Total Investment
      $88.3M
      Weight
      3.0%
      BOSTON SCIENTIFIC CORPORATION logo

      BSX - Manufacturing

      BOSTON SCIENTIFIC CORPORATION

      P/E-Ratio
      62.3
      Total Investment
      $85.5M
      Weight
      2.9%
      PFIZER INC. logo

      PFIZER INC.

      P/E-Ratio
      n/a
      Total Investment
      $78.3M
      Weight
      2.6%
      STRYKER CORPORATION logo

      SYK - Manufacturing

      STRYKER CORPORATION

      P/E-Ratio
      51.3
      Total Investment
      $76.6M
      Weight
      2.6%
      GILEAD SCIENCES, INC. logo

      GILD - Manufacturing

      GILEAD SCIENCES, INC.

      P/E-Ratio
      22.3
      Total Investment
      $75.3M
      Weight
      2.5%
      VERTEX PHARMACEUTICALS INCORPORATED logo

      VRTX - Manufacturing

      VERTEX PHARMACEUTICALS INCORPORATED

      P/E-Ratio
      27.6
      Total Investment
      $74.6M
      Weight
      2.5%
      DANAHER CORPORATION logo

      DHR - Manufacturing

      DANAHER CORPORATION

      P/E-Ratio
      43.2
      Total Investment
      $72.8M
      Weight
      2.5%
      MEDTRONIC PUBLIC LIMITED COMPANY logo

      MEDTRONIC PUBLIC LIMITED COMPANY

      P/E-Ratio
      n/a
      Total Investment
      $61.6M
      Weight
      2.1%
      BRISTOL-MYERS SQUIBB CO logo

      BMY - Manufacturing

      BRISTOL-MYERS SQUIBB CO

      P/E-Ratio
      -16.7
      Total Investment
      $57.6M
      Weight
      1.9%
      ELEVANCE HEALTH, INC. logo

      ANTM - Finance and Insurance

      ELEVANCE HEALTH, INC.

      P/E-Ratio
      13.4
      Total Investment
      $55.4M
      Weight
      1.9%
      THE CIGNA GROUP logo

      CI - Finance and Insurance

      THE CIGNA GROUP

      P/E-Ratio
      16.0
      Total Investment
      $51.8M
      Weight
      1.7%
      ZOETIS INC. logo

      ZTS - Manufacturing

      ZOETIS INC.

      P/E-Ratio
      26.7
      Total Investment
      $40M
      Weight
      1.3%
      HCA HEALTHCARE, INC. logo

      HCA - Health Care and Social Assistance

      HCA HEALTHCARE, INC.

      P/E-Ratio
      16.4
      Total Investment
      $36.2M
      Weight
      1.2%
      REGENERON PHARMACEUTICALS, INC. logo

      REGN - Manufacturing

      REGENERON PHARMACEUTICALS, INC.

      P/E-Ratio
      13.7
      Total Investment
      $35.4M
      Weight
      1.2%
      BECTON, DICKINSON AND COMPANY logo

      BDX - Manufacturing

      BECTON, DICKINSON AND COMPANY

      P/E-Ratio
      34.6
      Total Investment
      $33.9M
      Weight
      1.1%
      BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares logo

      BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares

      P/E-Ratio
      n/a
      Total Investment
      $27.6M
      Weight
      0.9%
      EDWARDS LIFESCIENCES CORPORATION logo

      EW - Manufacturing

      EDWARDS LIFESCIENCES CORPORATION

      P/E-Ratio
      11.5
      Total Investment
      $25M
      Weight
      0.8%
      HoMEÔçÒÒŮѸÀ×